Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas bought 132,572 shares of the firm’s stock in a transaction on Monday, March 3rd. The stock was acquired at an average price of $0.49 per share, for a total transaction of $64,960.28. Following the completion of the purchase, the chief executive officer now directly owns 4,029,588 shares in the company, valued at approximately $1,974,498.12. The trade was a 3.40 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Grigorios Siokas also recently made the following trade(s):
- On Monday, February 24th, Grigorios Siokas acquired 354,296 shares of Cosmos Health stock. The stock was bought at an average price of $0.56 per share, for a total transaction of $198,405.76.
- On Thursday, January 30th, Grigorios Siokas bought 51,414 shares of Cosmos Health stock. The shares were bought at an average price of $0.66 per share, with a total value of $33,933.24.
- On Wednesday, January 22nd, Grigorios Siokas acquired 38,900 shares of Cosmos Health stock. The shares were bought at an average price of $0.77 per share, for a total transaction of $29,953.00.
- On Friday, January 17th, Grigorios Siokas bought 29,158 shares of Cosmos Health stock. The stock was bought at an average price of $0.86 per share, with a total value of $25,075.88.
- On Wednesday, January 15th, Grigorios Siokas acquired 62,500 shares of Cosmos Health stock. The shares were purchased at an average price of $0.80 per share, for a total transaction of $50,000.00.
- On Monday, January 13th, Grigorios Siokas purchased 163,666 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.61 per share, for a total transaction of $99,836.26.
- On Friday, December 20th, Grigorios Siokas purchased 257,334 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.58 per share, with a total value of $149,253.72.
Cosmos Health Trading Up 7.1 %
NASDAQ COSM opened at $0.53 on Wednesday. The stock has a 50-day moving average of $0.68 and a 200-day moving average of $0.79. The company has a current ratio of 1.44, a quick ratio of 1.24 and a debt-to-equity ratio of 0.08. Cosmos Health Inc. has a 1-year low of $0.44 and a 1-year high of $1.58. The firm has a market cap of $12.21 million, a PE ratio of -0.22 and a beta of 5.60.
Institutional Investors Weigh In On Cosmos Health
About Cosmos Health
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Further Reading
- Five stocks we like better than Cosmos Health
- When to Sell a Stock for Profit or Loss
- GitLab: Get In While It’s Down—Big Rebound Ahead
- 5 Top Rated Dividend Stocks to Consider
- Tesla Stock: Finding a Bottom May Take Time
- Consumer Staples Stocks, Explained
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.